MSA-007

Atrofia multipli-sistemica (MSA)

亚洲 60岁 男 韩国 Total Cost: 212

Patient Condition

MSA-P, parkinsonismo progressivo per 18 mesi con scarsa risposta alla L-dopa. Grave ipotensione ortostatica, frequenza/urgenza urinaria e declino cognitivo precoce. UMSARS-I 21, UMSARS-II 26, SCOPA-AUT 21, MoCA 23.

Treatment Timeline

PhaseDetailsDate
基线评估与入组
自体脂肪干细胞治疗
随访评估

Treatment Outcome

beforeUMSARS-I 21分,UMSARS-II 26分,MoCA 23分,脑脊液NfL 78pg/mL
afterUMSARS-I改善至19分,UMSARS-II改善至23分,MoCA稳定在23分,脑脊液NfL降至58pg/mL(下降26%)
highlight自体AD-MSC鞘内注射显著改善了运动功能和自主神经症状,神经退行性标志物NfL明显下降,认知功能维持稳定